MELISSA RUBIANES: Open Payments
NPI 1518486356 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 3 payments from 3 companies in 2025. Trend: 2023 $3,554 · 2024 $1,792 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $149 |
| Janssen Biotech, Inc. | 1 | $123 |
| ABBVIE INC. | 1 | $22 |
Products named: Yescarta, RYBREVANT, IMBRUVICA.
Industry payments across NY — which companies pay providers there.
